Evidence map›Paper›PMID 38550584›Full record

ArticleFrontiers in immunology2024

Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS

Bernardo López-Andrade, Vanesa Cunill, Valero Andreu, Leyre Bento, Marina Segura-Guerrero, Andrea Moñino, Julio Iglesias, Maria Rosa Julià, Maria Antonia Durán, Maria Carmen Ballester and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Evaluating the Predictive Value of the Endothelial Activation and Stress Index in Determining the Severity and Prognosis of Acute Pulmonary Embolism.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bernardo López-AndradeDepartment of Hematology, Hospital Universitari Son Espases, Palma, Spain.
Vanesa CunillDepartment of Immunology, Hospital Universitari Son Espases, Palma, Spain.
Valero AndreuBalearic Islands Health Research Institute (IdISBa), Palma, Spain.
Leyre BentoDepartment of Hematology, Hospital Universitari Son Espases, Palma, Spain.
Marina Segura-GuerreroDepartment of Immunology, Hospital Universitari Son Espases, Palma, Spain.
Andrea MoñinoDepartment of Immunology, Hospital Universitari Son Espases, Palma, Spain.
Julio IglesiasDepartment of Immunology, Hospital Universitari Son Espases, Palma, Spain.
Maria Rosa JuliàDepartment of Immunology, Hospital Universitari Son Espases, Palma, Spain.
Maria Antonia DuránDepartment of Hematology, Hospital Universitari Son Espases, Palma, Spain.
Maria Carmen BallesterDepartment of Hematology, Hospital Universitari Son Espases, Palma, Spain.
Josep MuncunillBalearic Islands Health Research Institute (IdISBa), Palma, Spain.
Antonia SampolDepartment of Hematology, Hospital Universitari Son Espases, Palma, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: NETosis, the mechanism by which neutrophils release extracellular traps (NETs), is closely related to inflammation. During the allogeneic hematopoietic stem cell transplantation (allo-HSCT), different stimuli can induce NETs formation. Inflammation and endothelial injury have been associated with acute graft-versus-host disease (aGVHD) and complications after allo-HSCT. We focus on the study of NETosis and its relation with cytokines, hematological and biochemical parameters and clinical outcomes before, during and after allo-HSCT. Methods: We evaluate the capacity of plasma samples from allo-HSCT patients to induce NETosis, in a cell culture model. Plasma samples from patients undergoing allo-HSCT had a stronger higher NETs induction capacity (NETsIC) than plasma from healthy donors throughout the transplantation process. An optimal cut-off value by ROC analysis was established to discriminate between patients whose plasma triggered NETosis (NETs+IC group) and those who did not (NETs-IC group). Results: Prior to conditioning treatment, the capacity of plasma samples to trigger NETosis was significantly correlated with the Endothelial Activation and Stress Index (EASIX) score. At day 5 after transplant, patients with a positive NETsIC had higher interleukin (IL)-6 and C-reactive protein (CRP) levels and also a higher Modified EASIX score (M-EASIX) than patients with a negative NETsIC. EASIX and M-EASIX scores seek to determine inflammation and endothelium damage, therefore it could indicate a heightened immune response and inflammation in the group of patients with a positive NETsIC. Cytokine levels, specifically IL-8 and IL-6, significantly increased after allo-HSCT with peak levels reached on day 10 after graft infusion. Only, IL-10 and IL-6 levels were significantly higher in patients with a positive NETsIC. In our small cohort, higher IL-6 and IL-8 levels were related to early severe complications (before day 15 after transplant). Discussion: Although early complications were not related to NETosis by itself, NETosis could predict overall non-specific but clinically significant complications during the full patient admission. In summary, NETosis can be directly induced by plasma from allo-HSCT patients and NETsIC was associated with clinical indicators of disease severity, cytokines levels and inflammatory markers.

Indexed as

Hematopoietic Stem Cell TransplantationInterleukin-6CytokinesHumansInflammationInterleukin-8CytokinesInterleukin-6Interleukin-8aGVHDAllo-HSCTCytokinesEASIX scoreIL-6InflammationNETosisNETs

Identifiers

PMID38550584
PMCPMC10972998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.